About this trial
Unresectable hepatocellular carcinoma
Where’s this trial being run?
St Vincents University Hospital and Mater Misericordiae University Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
Phase 3 randomized, double-blinded, active-controlled clinical study to evaluate the safety and efficacy of lenvatinib in combination with pembrolizumab versus lenvatinib alone in first-line intervention of participants with unresectable hepatoceullar carcinoma
|Principal Investigator:||Ray McDermott|
|Global Recruitment Target:||750|
|Ireland Recruitment Target:|